# altcoin / # bitcoin / # blockchain / # exchange / # events / # ICO / # trends / # finance / # Russian news

Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff

2026-9-8 06:00 pm NEWS
Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.
Read The Rest at
marketwatch.com
novartis failed trial cholesterol leads broad biopharma stock selloff
SOURCE:

You May Also Like

1 Alexandr Wang wanted to make Meta 'cool again' — and memes were part of his plan
Alexandr Wang wanted to make Meta 'cool again' — and memes were part of his plan
2 Ethereum FOMO Meets Higher Binance Leverage Than Bitcoin
Ethereum FOMO Meets Higher Binance Leverage Than Bitcoin
3 China Buys Record Amount Of Gold As India Panics, Scraps Key Tax Relief On Precious Imports
China Buys Record Amount Of Gold As India Panics, Scraps Key Tax Relief On Precious Imports
4 Bitcoin Price Walks a Tightrope as Bears Circle the $82K Zone
Bitcoin Price Walks a Tightrope as Bears Circle the $82K Zone
5 Is America Winning The AI Race?
Is America Winning The AI Race?



© 2022 CRYPTONEWS
Cryptocurrency news – Bitcoin, etherium, altcoins, Blockchain, crypto exchange, law regulation | donate